Background: To date, Atrius Health has not assessed how often patients request additional pain medication after receiving an initial opioid for acute pain management. This assessment was requested to help justify prescribing patterns for opioids in the primary care setting. Objective: To assess the amount of requests for additional opioid prescriptions in patients who received a short-acting opioid for acute pain management. Methods: This was a retrospective chart review of a multicenter large ambulatory care organization in the Greater Boston Area. Atrius Health patients who received an initial prescription for a short-acting oral opioid indicated for acute pain management between May 1, 2016, and October 1, 2016, were included in the study. Results: The overall percentage of patients requesting additional medication for acute pain management was 13% (46/350). Of the 46 patients who requested additional medication, 15 patients received a second opioid prescription (33%, 15/46). For those patients who requested additional pain medication, there were no trends between the day supply that was prescribed and a patient receiving a second opioid prescription from a health care provider. Patients who received a 4-to 5-day supply of opioids were not more likely to call back requesting additional pain medication than patients who received a 1-to 3-day supply of opioids (odd ratio = 0.41; 95% confidence interval = 0.17-1.00). Conclusion: At Atrius Health, roughly 13% of patients are requesting additional pain medications after being prescribed a short-acting opioid for acute pain management. Other primary care and urgent care health systems may consider reducing the day supply of opioids prescribed for acute pain management.
Background
The Centers for Disease Control & Prevention (CDC) estimates that opioid analgesic use has quadrupled in the United States between 1999 and 2010. 1 Specifically, in the state of Massachusetts, opioid-related deaths began increasing in 2012, yet there was no similar increase in opioid prescriptions. 2 This is evidence that opioid-related deaths are complex issues with many contributing factors. For example, an opioid-related death may be due to an accidental overdose or illicit use of the drug. A study conducted by Cicero et al found an increase from 8.7% in 2005 to 33% in 2015 in opioid initiators starting with heroin. 3 Their data show that the use of heroin as an initiating opioid has grown at an alarming rate.
In the state of Wisconsin, a drug take-back program was conducted, and the results showed that the average supply of a short-acting opioid dispensed was 5.8 days and the average supply remaining was 3.3 days. 4 A retrospective study was conducted in Utah that found that 72% of patients who received a prescription for an opioid in the previous 12 months had medication remaining at their home. 5 Studies have been conducted to show that patients tend to have opioids remaining when prescribed for acute pain management. [4] [5] [6] A retrospective study conducted including opioid naïve patients undergoing surgery found that the total duration of opioid use was the strongest indicator for misuse. 7 Furthermore, Brat et al 7 found that each additional week of opioid use postoperatively was associated with an increased risk for misuse.
In the state of Massachusetts, roughly 1 in 6 residents obtained an opioid prescription from a health care provider in 2015. 2 According to the CDC, primary care providers account for about half of all prescription opioid pain relievers dispensed. 8 Since Atrius Health is mainly composed of primary care and urgent care clinicians in Massachusetts, an opportunity to assess opioid prescribing habits and patient responses was needed. Claims-based data for quarter 1 of 2016 at Atrius Health found that the average supply of short-acting opioids being dispensed to patients was 7 days. To date, it has not been assessed how often patients request additional pain medication after receiving an initial opioid and whether or not the physician is prescribing additional opioid medications for acute pain management.
Objectives
The objective of this study was to assess the percentage of patients who requested additional pain medications after receiving an initial oral short-acting opioid for acute pain management. Secondary objectives were to assess if there was an association between the day supply of opioids provided to a patient, pain diagnoses assigned to patients, or concomitant medications taken by patients and the potential to request additional pain medication.
Methods
This study was a retrospective chart review of patients treated at 21 Atrius Health primary care and urgent care clinical sites in the state of Massachusetts. Prior to retrieval of data, the study protocol was approved by the MCPHS University Institutional Review Board. Eligible Atrius Health patients were included if they received an initial prescription for a short-acting, immediate-release, oral opioid that was a 14-day supply or less between May 1, 2016, and October 1, 2016. Prescriptions had to be prescribed by an Atrius Health provider for acute pain management. Patients were not included in the study if they were <18 years of age; had acute pain related to a diagnosis of cancer; were receiving palliative care at the time of prescribing; separate acute pain episode within 30 days; had chronic opioid prescriptions during the acute pain episode or a pain management agreement on file in the electronic medical record (EMR); if the first prescription for acute pain management was given from an outside facility (emergency department, inpatient hospital stay, surgical center, etc); any prescription that was prescribed for a condition other than acute pain as determined by a chart review. These exclusion criteria were chosen to best ensure that the first prescription prescribed for a patient came from an Atrius Health provider for an acute pain situation.
The primary objective was to determine the percentage of additional requests for pain medication after a short-acting opioid prescription was initially prescribed for a 14-day supply or less for acute pain management. Secondary objectives were to determine if there was an association between the day supply of opioids provided to a patient and the patient requesting additional medication; determine if there was an association between certain pain diagnoses and requests for additional pain medication; determine if the use of select concomitant medications had an effect on a patient requesting additional pain medication. These objectives were chosen to help evaluate and assess prescribing patterns for short-acting opioids indicated for acute pain management. These objectives were also included to identify if there were certain patient characteristics that would lead to more requests for pain medication and to add to the scarce data regarding requests for additional pain medication.
Patients would be considered as a "yes" to requesting additional pain medication if they had called the practice, presented to the clinic in person, or messaged the clinician electronically requesting additional pain medication. This request had to occur within 7 days after the initial opioid prescription was due to end based on maximum usage from the initial supply provided. Maximum usage was calculated assuming the patient was taking their prescription as prescribed on the label around the clock.
A sample size of 328 patients was predetermined using NCSS 2007 and was based on the anticipated number of patients that would meet inclusion criteria at Atrius Health in the given time frame and the estimated amount of chart review required. Eligible patients were identified through the use of the institution's EMR. A comprehensive chart review was conducted by the primary investigator to obtain the following values: patient age, gender, race or ethnicity, body mass index, initial day supply of the opioid, history of smoking use, history of substance abuse, history of depression/anxiety/other psychiatric comorbidities (if available), concomitant medications the patients were taking at the time of the opioid being prescribed, indication for the opioid, if the pain was due to a surgical procedure; details about that procedure were collected as well, if the patient requested additional pain medication in the following 7 days after the initial prescription was due to end by calculation of maximum usage, if the patient received a second opioid prescription, and the second opioid medication details as well. Data was collected between May 1, 2016, and October 1, 2016.
Statistical Analysis
The primary investigator and a statistician at MCPHS University conducted all statistical analyses using NCSS 2007 and Microsoft Excel 2016. Percentages and fractions were documented using Microsoft Excel 2016. All subanalysis was performed using NCSS 2007 with a logistic regression model for the odds ratios (ORs) calculated. ORs and 95% confidence intervals (CIs) were calculated for each variable to determine if certain patient characteristics would be more or less likely to result in a patient requesting additional pain medication. Higher ORs represented a higher likelihood of a patient requesting additional pain medication, while lower ORs represented a lower likelihood of a patient requesting additional pain medication.
Results
A total of 350 patients were identified as meeting criteria for inclusion into the study, with 1092 patients excluded. Reasons for exclusion were the following: patients who were receiving long-acting chronic opioids, patients recently discharged from an outside facility (emergency department, inpatient hospital stay, surgical center, etc), postoperative prescriptions prescribed before the date of surgery, patients receiving chemotherapy concomitantly, and patients who had a surgery outside of Atrius Health.
The majority of patients in this study were white females with an average age of 54 years who were receiving an opioid for back pain, outpatient surgical procedures, or shoulder pain. A total of 50.9% of patients were nonsmokers, 36.3% were former smokers, and 12.9% were current smokers. About 3% of patients had a history of reported substance abuse, 17.7% had anxiety, and 12.6% had a diagnosis of depression (Table 1) .
On average, patients were prescribed a 4.16-day supply of short-acting opioids. This is a decrease from a roughly 7-day supply of short-acting opioids based on claims-based data previously mentioned. The overall percentage of patients requesting additional medication for pain management was 13% (46/350). Of those 46 patients who called back requesting additional medication, 15 patients received a second opioid prescription for acute pain management, 33% (15/46).
When assessing the initial supply that was prescribed for the opioid, it was found that patients who received a 4-to 5-day supply of opioids were not more likely to call back requesting additional pain medication than patients who received a 1-to 3-day supply of opioids (OR = 0.41; 95% CI = 0.17-1.00; see Table 2 and Figure 1 ). It was also found that patients who received a 6-to 7-day supply of opioids were less likely to call back requesting additional medication than patients who received a 1-to 3-day supply of opioids (OR = 0.10; 95% CI = 0.01-0.85; Table 2 ). Patients receiving an 8-to 14-day supply were not found to be more likely to request additional medication than patients who received a 1-to 3-day supply of opioids (OR = 1.59; 95% CI = 0.47-5.43; Table 2 ). For those patients who requested additional pain medication, it was also found that there were no trends between the supply that was prescribed and a patient receiving a second opioid prescription from the health care provider.
When assessing medications that patients were taking at the time of prescribing, patients who were prescribed gabapentin were found to be more likely to request additional pain medication than those patients who were reported to be taking no medication (OR = 2.07; 95% CI = 2.08-19.58; Table 2 ). The patients who received gabapentin were reviewed in a subanalysis, and it was found that there was no common initial indication for pain among the patients who requested additional pain medication (n = 8). Of note, patients taking common nonprescription medications such as acetaminophen or ibuprofen were not likely to request additional pain medication than those patients who were reported to be taking no concomitant medications (OR = 1.01, 95% CI = 0.35-2.88; OR = 1.49, 95% CI = 0.63-3.51, respectively; Table 2 ). In addition, patients taking benzodiazepines (clonazepam, lorazepam, diazepam, alprazolam) or muscle relaxants (cyclobenzaprine, methocarbamol) were not likely to request additional pain medications than those patients who were reported to be taking no concomitant medications (OR = 2.07, 95% CI = 0.82-5.24; OR = 3.15, 95% CI = 0.78-12.68, respectively; Table 2 ). Other pain indications included abdominal, foot, groin, ear, jaw, hip, knee, leg, rip, menstrual, gout, arthritic pain, cellulitis pain, and burn wounds.
It was found that there was no association between any of the most common indications for pain medications that were measured and whether or not a patient was going to request additional pain medication (Table 3) .
When looking at a subset of patients based on their smoking status, it was found that patients who were labeled as a former smoker were more likely to request additional pain medication than patients who were nonsmokers (OR = 2.79; 95% CI = 1.15-6.78; Table 2 ).
Discussion
According to the American College of Physicians, for patients with acute or subacute low back pain, clinicians should reassure patients that this usually improved over time, regardless of treatment. 9 This may be an area for potential reduction of opioids prescribed within our health system as 26.8% (94/35) of patients prescribed an opioid had some form of back pain. It has also been found that in postoperative patients, the combination of an opioid with a nonopioid analgesic was more effective than any one opioid. 10, 11 In this study, the majority of patients received an opioid in the form of a combination tablet with a nonopioid analgesic for the treatment of their acute pain. In those patients who received opioid non-combination tablets, often a nonopioid analgesic was recommended/prescribed as well.
For the treatment of low back pain, according to the American College of Physicians and American Pain Society, opioid analgesics are an option when used judiciously in patients who have severe, debilitating pain that is not relieved with acetaminophen, nonsteroidal anti-inflammatory drugs, or other pharmacologic and nonpharmacologic therapies. 9, 12 Failure to respond to a time-limited course of opioids should lead to the patient being reassessed for alternative therapies. 12 Based on the 2017 guidelines for chronic low back pain by Qaseem et al, when strong opioids versus placebo were prescribed for chronic low back pain the magnitude Muscle relaxants included cyclobenzaprine and methocarbamol. d Selective serotonin reuptake inhibitors included citalopram, fluoxetine, paroxetine, and sertraline. e Listed on the electronic medical record problem list was "behavioral health," indicating these patients have a mental health illness.
of effect for pain and function was "small" based on moderate strength evidence. 9 It is unclear why patients who received gabapentin were more likely to request pain medications. This study was not powered to measure this variable and thus we can only make an association based on the data. This association may be due to patients receiving gabapentin having a higher pain rating than those not receiving gabapentin. This study did not evaluate a pain scale when reviewing patient charts and may be considered a limitation. Another reason why a patient concomitantly taking gabapentin may be more likely to request additional pain medication is due to their neuropathy not being properly treated before the acute pain event leading to an opioid prescription. Once the opioid was prescribed and the neuropathic pain was adequately managed, the patient may have requested additional pain medication to continue control of the pain.
Our study found that patients who were given an opioid for acute low back pain were not more likely to request additional pain medication as compared to other pain indications (OR = 1.34; 95% CI = 0.60-3.00; Table 3 ). Overall, 14.9% of patients who were given an opioid for back pain requested additional pain medication.
Our study had several limitations. This study was a retrospective chart review; information gathered was dependent on the information available in the EMR (no patients were contacted during this study); patient requests for additional pain medication were dependent on a medical secretary This study did collect data pertaining to the patient's history of psychiatric comorbidities; however, the data were limited due to the reporting style of a psychiatric comorbidity in the EMR and that information was unable to be fully obtained, thus only anxiety, depression, and substance abuse were included. If a psychiatric comorbidity was reported readily on the problem list in the EMR, it was documented and results were reported ( Table 2 ). The lack of reporting posttraumatic stress disorder comorbidity is a limitation as it has been noted that veterans and civilians with posttraumatic stress disorder are more likely to receive prescription opioids than those with no diagnosis or with other psychiatric comorbidities. 13 This study did not collect morphine milligram equivalents per day. Future studies including morphine milligram equivalents data may be used to better study the prescribing patterns of physicians within the health system and the correlation with additional pain medication requests.
Results from this study may help reinforce prescribing of shorter day supplies of opioids for acute pain management. Only 13% of patients reviewed requested a second opioid prescription. This raises a question about the other 87% of patients who did not request a second opioid prescription. Did those patients have exactly the right amount of opioids or extra opioids at home? Based on studies previously mentioned, most patients tend to have opioids remaining at home. [4] [5] [6] The majority of patients who received a short day supply of an opioid did not request additional opioids.
Shorter, 1-to 3-day supplies of opioids for acute pain management showed no significant increase in requests for additional pain medications than 4-to 5-day supplies of opioids. By reducing the amount of opioids dispensed, the amount of opioids that are remaining in patient homes should theoretically decrease and thus reduce the potential for diversion of unused opioids.
Conclusion
Patients who receive a short-acting opioid for acute pain management at Atrius Health are requesting additional pain medication approximately 13% of the time irrespective of the indication for pain or day supply prescribed. Other primary care and urgent care health systems may consider reducing the day supply of opioids prescribed for acute pain management. Further randomized controlled data are needed to characterize the circumstances that result in the requests for additional pain medication.
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